These data suggest upon treatment with IRE1α inhibitors, BIM was activated by JNK phosphorylation as well as heterodimerization with BAX to promote cell apoptosis of pancreatic cancer cells. The gene discussed is BAX; the disease is familial pancreatic carcinoma.